| Literature DB >> 30332336 |
Eva Espadale1, Gina Pinchbeck2, Nicola J Williams2, Dorina Timofte1,3, K Marie McIntyre2, Vanessa M Schmidt1.
Abstract
Hand hygiene (HH) is the most successful intervention for hospital infection control. HH rubs with residual action are desired. This study aimed to compare the efficacy of alcohol (A-HH) and lactic acid (LA-HH) rubs, with the latter being marketed as having residual activity. We investigated reductions in bacterial colony-forming units (CFUs), prevalence of antimicrobial-resistant (AMR) organisms, and risk factors for increased counts on the hands of veterinary staff. A randomized, crossover study (53 individuals) was performed in a referral veterinary teaching hospital. Hand plates were taken before, immediately after, and 6 hours after HH. A blinded investigator counted CFUs per plate. Methicillin-resistant Staphylococcus aureus/pseudintermedius (MRSA/MRSP), Enterobacteriaceae, and Pseudomonas species (spp.) were characterized. Gender, profession, time point, and HH product were included as variables within multivariable analyses. A significant reduction in bacterial CFU was seen immediately after A-HH rub application (p < 0.001); however, neither product showed any significant residual action. Veterinarians had higher bacterial CFUs than nurses (p = 0.005); contact with patients, rather than the environment, was also associated with higher counts (p < 0.001). MRSA, MRSP, Enterobacteriaceae spp., and Pseudomonas spp. were detected on 7%, 2%, 14%, and 2% of study participant's hands (n = 208 samples), respectively. Frequent HH administration using an A-HH rub was effective at reducing bacterial CFU on hands in vivo in this veterinary hospital setting, but its use needs further encouragement in veterinary staff. The high prevalence of antimicrobial bacteria on hands is of concern; they might act as reservoirs for patients, the environment, and in-contact people.Entities:
Keywords: alcohol hand hygiene rub; antimicrobial-resistant bacteria; hand hygiene; lactic acid hand hygiene rub
Mesh:
Substances:
Year: 2018 PMID: 30332336 PMCID: PMC6306656 DOI: 10.1089/mdr.2018.0183
Source DB: PubMed Journal: Microb Drug Resist ISSN: 1076-6294 Impact factor: 3.431

Schematic view of methods. CAB, Columbia 5% defibrinated horse blood agar; CFU, colony-forming units; TSB, tryptone soy broth; EMBAcx, Eosin Methylene Blue with cefotaxime (1 mg/L); PseudCN, Pseudomonas CN 200 mg/L (Cetrimide and 15 mg/L Sodium Nalidixate); CBA, Chromogenic Brilliance Agar; NA, nutrient agar; OX, oxacillin; FOX, cefoxitin; CD, clindamycin; E, erythromycin; TS/STX, trimethoprim-sulfamethoxazole; C, chloramphenicol; T, tetracycline; FA, fusidic acid; GM, gentamicin; RP, rifampin; ENR, enrofloxacin; MAR, marbofloxacin; AK, amikacin; AP, ampicillin; AUG, amoxicillin clavulanate; CPD, cefpodoxime.
Microbiological Efficacy of Two Hand Hygiene Products on Colony-Forming Units in 51 Study Participants Who Provided Paired Data for Analysis
| p | p | p | ||||
|---|---|---|---|---|---|---|
| Lactic acid | 84 (156) | 209 (178) | 83 (133) | 0.222 | ||
| Alcohol | 88 (113) | 19 (52) | 85 (138) | 0.417 | ||
| 0.781 | 0.647 | |||||
Bold values indicate p < 0.05.
Dominant hand; n = total number of participants providing paired data for statistical analysis comparing the HH rubs; T1—after patient/environmental contact and before HH, T2—immediately after HH, T3—6–8 hours later, just before going home.
p value for Wilcoxon signed rank test (Wilcox) comparing CFU for lactic acid and alcohol rub groups at T1, T2, and T3.
p value for Wilcox comparing CFUs for products separately between T1 and T2.
p value for Wilcox comparing CFUs for products separately between T2 and T3.
p-Value for Wilcox comparing CFUs for products separately between T1 and T3.
CFU, colony-forming units.
Multilevel, Multivariable Regression Model Describing Factors Associated with Overall Hand Contamination After Hands Had Been Treated Using Either Lactic Acid- or Alcohol-Based Hand Hygiene Products
| Intercept | 1.41 | 0.11 | — |
| Product | 0.9 | ||
| Alcohol | Ref | — | — |
| Lactic acid | −0.001 | 0.06 | |
| Type of contact | |||
| Environment | Ref | — | — |
| Animal | 0.214 | 0.05 | |
| Job | |||
| Nurse | Ref | — | — |
| Administration staff | 0.388 | 0.201 | |
| Auxiliaries | 0.394 | 0.209 | |
| Veterinarians | 0.358 | 0.127 | |
| Students | 0.113 | 0.143 | |
| Time | |||
| T1 | Ref | — | — |
| T2 | −0.75 | 0.06 | |
| T3 | −0.18 | 0.06 | |
| Time*product interaction | |||
| Lactic acid* T1 | Ref | — | — |
| Lactic acid* T2 | 1.04 | 0.09 | |
| Lactic acid*T3 | 0.08 | 0.09 |
The outcome is the log colony-forming units, and the model includes clustering within participants (53 participants and 912 samples).
Ref, used as the baseline reference in the multilevel modeling; SE, standard error; bold values indicate p < 0.05. T1—after patient/environmental contact and before HH, T2—immediately after HH, T3—6–8 hours later, just before going home. The log CFU at each time point for each product after taking into account the interaction is shown below:
Number (N) and Prevalence (%), Including 95% Confidence Intervals of Participants with Hand Plates Positive for MR-CoPS, AMR Enterobacteriaciae spp., or Pseudomonas spp. Detected on Hands at T1 and T3 for Each Tested Product
| MR-CoPS | 4 | 3 | 7 | 5 | 8 | 13 | 20 |
| 7% (3–18) | 6% (2–16) | 7% (3–13) | 10% (2–10) | 15% (8–28) | 13% (7–20) | 10% (6–14) | |
| MRSA | 3 | 2 | 5 | 4 | 5 | 9 | 14 |
| 6% (2–15) | 4% (1–13) | 5% (2–10) | 10% (4–20) | 10% (4–20) | 9% (4–15) | 7% (4–11) | |
| MRSP | 0 | 1 | 1 | 2 | 2 | 4 | 5 |
| 2% (0–10) | 1% (0–5) | 4% (1–13) | 4% (1–13) | 4% (2–9) | 2% (1–6) | ||
| AMR Enterobacteriaceae spp. | 9 | 10 | 19 | 2 | 9 | 11 | 30 |
| 17% (9–30) | 19% (10–32) | 18% (12–27) | 4% (1–13) | 17% (9–30) | 11% (6–18) | 14% (10–20) | |
| 3GCR[ | 7 | 6 | 13 | 2 | 6 | 8 | 21 |
| 13% (7–25) | 12% (5–23) | 13% (7–20) | 4% (1–13) | 12% (5–23) | 8% (4–14) | 10% (7–15) | |
| MDR | 2 | 1 | 3 | 0 | 3 | 3 | 6 |
| 4% (1–13) | 2% (0–10) | 3% (1–8) | 6% (2–16) | 3% (1–8) | 3% (1–6) | ||
| | 3 | 1 | 4 | 0 | 1 | 1 | 5 |
| 6% (2–16) | 2% (0–10) | 4% (2–9) | 2% (0–10) | 1% (0–5) | 2% (1–6) | ||
| | 2 | 0 | 2 | 0 | 1 | 1 | 3 |
| 4% (1–13) | 2% (1–7) | 2% (0–10) | 1% (0–5) | 1% (0–4) | |||
| | 3 | 0 | 3 | 0 | 0 | 0 | 3 |
| 6% (2–16) | 3% (1–8) | 1% (0–4) | |||||
| | 1 | 0 | 1 | 0 | 1 | 1 | 2 |
| 2% (0–10) | 1% (0–5) | 2% (0–10) | 1% (0–5) | 1% (0–3) | |||
| | 3 | 1 | 2 | 0 | 6 | 6 | 8 |
| 6% (2–16) | 2% (0–10) | 2% (1–7) | 12% (5–23) | 6% (3–12) | 3% (2–7) | ||
| 1 | 2 | 3 | 0 | 2 | 2 | 5 | |
| 2% (0–10) | 4% (1–13) | 3% (1–8) | 4% (1–13) | 2% (1–7) | 2% (1–6) | ||
Phenotypic resistance to cefpodoxime (CPD).
These genes not sequenced to determine if they were ESBL gene variants.
N, number of positive samples; n, number of participants; CI, confidence interval; T1—after patient/environmental contact and before HH; T3—end of the day, before leaving the work place; AMR, antimicrobial resistant; MR-CoPS, methicillin-resistant coagulase-positive staphylococci; MRSA, methicillin-resistant Staphylococcus Aureus; MRSP, methicillin-resistant Staphylococcus pseudintermedius; AMR Enterobacteriaceae spp., Enterobacteriaceae spp. isolates resistant to at least one tested antimicrobial; 3GCR, third-generation cephalosporin resistance; MDR, multidrug resistant (resistant to three or more antimicrobial classes).
| T1 | 1.412 | 1.413 |
| T2 | 1.704 | 0.663 |
| T3 | 1.316 | 1.232 |